Buoyant density of hepatitis C virus recovered from infected hosts: Two different features in sucrose equilibrium density‐gradient centrifugation related to degree of liver inflammation

Hepatitis C virus is reported to have a low buoyant density in sucrose. To determine the density of hepatitis C virus in the circulation of infected hosts and its association with the degree of liver inflammation, we examined serum samples from 10 patients who were positive for both hepatitis C virus antibody (C100 antigen) antibody and serum hepatitis C virus RNA. After the serum was ultracentrifuged in sucrose density gradient (10 to 60), the hepatitis C virus RNA titer in each collected fraction was quantified by means of competitive reverse transcription–polymerase chain reaction. In samples from five blood donors, the hepatitis C virus RNA titer had a single peak at fractions with densities of 1.08 to 1.11 gm/ml. In samples from five patients with ALT abnormalities, the titer had two peaks at fractions with 1.09 to 1.10 gm/ml and 1.22 to 1.25 gm/ml. After the selected samples were treated with detergents and ultracentrifuged, the titer in the 1.08 to 1.11 gm/ml fractions decreased and that in the 1.22 to 1.25 gm fractions increased. This result implied that the hepatitis C virus density changed with removal of the viral envelope by lipid solvents. Thus the buoyant density of hepatitis C virus in sucrose was 1.08 to 1.11 gm/ml for an intact virion and 1.22 to 1.25 gm/ml for what was presumed to be a nucleocapsid. These results demonstrated that HCV virion is a dominant form in the circulation of blood donors without ALT abnormalities. In patients with liver inflammation HCV particles with higher densities of 1.22 to 1.25 gm/ml coexist with virion in the circulation, which might be presumed nucleocapsids. (Hepatology 1994;19:296–302).

[1]  A. Kasahara,et al.  Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. , 1993 .

[2]  R. Purcell,et al.  Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes , 1993, Journal of virology.

[3]  N. Hayashi,et al.  Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. , 1993, Gastroenterology.

[4]  S. Mishiro,et al.  p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. , 1992, Virology.

[5]  R. Carrick,et al.  Examination of the buoyant density of hepatitis C virus by the polymerase chain reaction. , 1992, Journal of virological methods.

[6]  B. Irvine,et al.  At least five related, but distinct, hepatitis C viral genotypes exist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Hayashi,et al.  Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: Implications for hepatitis C virus replication in infected tissue , 1992, Hepatology.

[8]  S. Mishiro,et al.  Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts. , 1992, The Journal of general virology.

[9]  S. Mishiro,et al.  Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. , 1992, The Journal of general virology.

[10]  H. Okamoto,et al.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. , 1992, The Journal of general virology.

[11]  Keiji Ueda,et al.  Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon‐α , 1992 .

[12]  H. Okamoto,et al.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. , 1991, The Journal of general virology.

[13]  T. Miyamura,et al.  The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. , 1991, The Journal of general virology.

[14]  D. Bradley,et al.  Hepatitis C virus: Buoyant density if the factor VIII‐derived isolate in sucrose , 1991, Journal of medical virology.

[15]  N. Kato,et al.  Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Barr,et al.  Genetic organization and diversity of the hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Okayama,et al.  Structure and organization of the hepatitis C virus genome isolated from human carriers , 1991, Journal of virology.

[18]  T. Sugimura,et al.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  N. Enomoto,et al.  There are two major types of hepatitis C virus in Japan. , 1990, Biochemical and biophysical research communications.

[20]  R. Purcell,et al.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Becker‐André,et al.  Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). , 1989, Nucleic acids research.

[22]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[23]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[24]  M. Shapiro,et al.  Determining the size of non-A, non-B hepatitis virus by filtration. , 1987, The Journal of infectious diseases.

[25]  D. Bradley,et al.  Posttransfusion non-A, non-B hepatitis in chimpanzees: Physicochemical evidence that the tubule-forming agent is a small, enveloped virus , 1985 .

[26]  D. Bradley,et al.  Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. , 1985, Gastroenterology.

[27]  R. Purcell,et al.  Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform , 1983, Infection and immunity.

[28]  D. Bradley,et al.  Posttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents , 1983, The Journal of infectious diseases.

[29]  R. Hirsch The complement system: its importance in the host response to viral infection , 1982, Microbiological reviews.

[30]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[31]  M. Oldstone,et al.  Antibody-complement interactions with purified lymphocytic choriomeningitis virus. , 1976, Virology.

[32]  V. Stollar Immune lysis of Sindbis virus. , 1975, Virology.

[33]  D. Burger,et al.  The role of sensitizing antibody in the neutralization of equine arteritis virus by complement or anti-IgG serum. , 1973, Virology.